News from FASEB: RC-522 provides cardioprotection without prodysrhythmic effects April 26, 1999 No Comments
Proteasome inhibitor PS-519 demonstrates cardioprotective activity in preclinical model April 26, 1999 No Comments
Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis April 20, 1999 No Comments
News from FASEB: ETA antagonist with potential in the treatment of pulmonary hypertension April 19, 1999 No Comments
RSS